Evolving Market Trends In The Cell And Gene Therapy Supply Chain/Logistics Industry: Advancements In Technology Propel Cell And Gene Therapy Logistics

The Cell And Gene Therapy Supply Chain/Logistics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Cell And Gene Therapy Supply Chain/Logistics Market Size During the Forecast Period?
The Cell And Gene Therapy Supply Chain/Logistics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Cell And Gene Therapy Supply Chain/Logistics Market Size During the Forecast Period?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12631

What Are the High-Growth Segments in the Cell And Gene Therapy Supply Chain/Logistics Market?
The cell and gene therapy supply chain/logistics market covered in this report is segmented -

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp

What Key Drivers Are Expected to Influence Future Cell And Gene Therapy Supply Chain/Logistics Market Growth?
The demand for cell and gene therapies, designed to alter cells or genes for the treatment of diseases, is rising and consequently propelling the growth of the associated supply chain or logistics market. These innovative therapies, possibly revolutionary for conditions previously considered untreatable, necessitate appropriate storage and handling, achievable through supply chain and logistics services. These services take care of everything from procurement to distribution and storage of these therapies. As per a report by the American Society of Gene & Cell Therapy, a reputable US-based medical and scientific establishment, there was a 10% quarterly growth in Phase III clinical trials of gene therapies in Q3 2023, the first rise since Q3 2022. Hence, the escalating demand for these therapies sustains the momentum in the cell and gene therapy supply chain or logistics market.

Which Companies Hold the Largest Share Across Different Cell And Gene Therapy Supply Chain/Logistics Market Segments?
Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

What Trends Are Driving Growth in The Cell And Gene Therapy Supply Chain/Logistics Market?
The upward surge of modern tech platforms in the cell and gene therapy supply chain/logistics market is an increasingly notable trend. To maintain their market standings, leading companies are innovating these state-of-the-art platforms for cell and gene therapies. For example, AmerisourceBergen Corporation, a leading US healthcare company that specializes in cell and gene therapy logistics, introduced the Cell and Gene Therapy (CGT) Integration Hub in April 2023. This integration hub benefits from the company's inventive customer relationship management (CRM) system and enhances biopharma platform integration for improved supervision of cell and gene therapy production and distribution.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

What Are the Emerging Geographies for The Cell And Gene Therapy Supply Chain/Logistics Market Growth?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cell And Gene Therapy Supply Chain/Logistics Market?
2. What is the CAGR expected in the Cell And Gene Therapy Supply Chain/Logistics Market?
3. What Are the Key Innovations Transforming the Cell And Gene Therapy Supply Chain/Logistics Industry?
4. Which Region Is Leading the Cell And Gene Therapy Supply Chain/Logistics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.